BUY Hindalco Industries Ltd. — Rajesh Palviya, Axis Securities
byRajesh Palviya, Axis SecuritiesHorizon: NA (inferred Swing (≤2wk))6 Aug 2026via Business Today
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Hindalco shares will react to Novelis earnings beat; debt remains an overhang
NewsCnbc-Tv18·6 Aug · today
Novelis Q1 Review: Brokerages Back Hindalco's Unit Recovery, Capacity Ramp-Up — Check Target Price, Potential Upside
NewsNdtv-Profit·6 Aug · today
Hindalco breaks out of key reversal pattern; SMC Global sees further upside
NewsEt-Markets·6 Aug · today
Novelis Q1 Results: Hindalco Arm Posts 128% Jump In Core Profit Even As Shipments Dip
NewsNdtv-Profit·5 Aug · today
Novelis Q1 profit jumps 71% as Hindalco arm gains from aluminium demand, cost savings
NewsCnbc-Tv18·5 Aug · today
Hindalco Industries Limited announced that its wholly owned subsidiary, Novelis Inc., has released its Q1 FY27 results. The results include financial highlights and an earnings presentation.
NSE · Press Release·5 Aug · today
Why Hindalco wants to build a nuclear reactor
NewsLivemint·31 Jul · 6d ago
Novelis Inc., a subsidiary of Hindalco Industries, has entered into a Material Definitive Agreement for a $500 million short-term unsecured term loan facility. The filing was made via Form 8-K.
BSE · Company Update·27 Jul · 1w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Hindalco Industries
- BUY — Nomura India Research22 Oct 2026 · ~1 year · target ₹1,100 · Active
- BUY — Motilal Oswal21 Oct 2026 · ~1 year · target ₹1,170 · Active
- BUY — Vaishali Parekh, Prabhudas Lilladher19 Oct 2026 · ~2 weeks · target ₹960 · Active
- BUY — Pradip Hotchandani, Prudent Corporate Advisory Services19 Oct 2026 · ~2 weeks · target ₹960 · SL hit
- SELL — Raja Venkatraman9 Oct 2026 · ~3 months · target ₹815 · Active
More from Rajesh Palviya, Axis Securities
- BUY Sansera Engineering8 Oct 2026 · ~2 weeks · target ₹4,350 · SL hit
- BUY Trent8 Oct 2026 · ~2 weeks · target ₹3,050 · SL hit
- SELL Sun Pharmaceutical Industries5 Oct 2026 · ~3 months · target ₹1,720 · SL hit
- BUY Cipla29 Sept 2026 · ~2 weeks · target ₹1,480 · SL hit
- BUY Zydus Lifesciences29 Sept 2026 · ~2 weeks · target ₹1,280 · SL hit

